The Week in Review #33
WE CALL IT THE BAD MARKET

The Federal Reserve’s raising of the interest rate does not and should not mean a demise of the companies trading on the NASDAQ and other stock exchanges. The biotech group of firms with strong scientific fundamentals will not stop innovating and bringing breakthroughs to millions of people who are desperate for them if an irrelevant selloff continues to occur every now and then. The market can even decide to commit apoptosis (suicide), bringing down with it all the prices of stocks belonging . . .